TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
665
|
2,858
|
1,386 |
| Financial expenses |
3
|
3
|
1 |
| Earnings before taxes |
-178
|
510
|
4 |
| EBITDA |
-166
|
522
|
16 |
| Total assets |
1,030
|
1,278
|
1,885 |
| Current assets |
789
|
1,234
|
1,883 |
| Current liabilities |
147
|
215
|
1,243 |
| Equity capital |
854
|
1,004
|
642 |
| - share capital |
45
|
45
|
49 |
| Employees (average) |
5
|
5
|
6 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
82.9%
|
78.6%
|
34.1% |
| Turnover per employee |
133
|
572
|
231 |
| Profit as a percentage of turnover |
-26.8%
|
17.8%
|
0.3% |
| Return on assets (ROA) |
-17.0%
|
40.1%
|
0.3% |
| Current ratio |
536.7%
|
574.0%
|
151.5% |
| Return on equity (ROE) |
-20.8%
|
50.8%
|
0.6% |
| Change turnover |
-2,202
|
1,585
|
-262 |
| Change turnover % |
-77%
|
124%
|
-16% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-17%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.